By Christine Harper and Saijel Kishan Goldman Sachs Group Inc. is shutting its principal-strategies business, a group that makes bets with the firm’s own capital,
By James Gallagher Stem cell researchers are heralding a “major scientific discovery”, with the potential to start a new age of personalised medicine. Scientists in
Former hedge fund manager Shah Gilani notes: In creating MERS, these institutions actually changed the land-title system that this country – for much of its
